- Home
- NX vs COLL Comparison
NX vs COLL Comparison
Compare NX & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NX
- COLL
- Stock Information
- Founded
- NX 1927
- COLL 2002
- Country
- NX United States
- COLL United States
- Employees
- NX N/A
- COLL N/A
- Industry
- NX Metal Fabrications
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- NX Industrials
- COLL Health Care
- Exchange
- NX Nasdaq
- COLL Nasdaq
- Market Cap
- NX 1.1B
- COLL 910.2M
- IPO Year
- NX N/A
- COLL 2015
- Fundamental
- Price
- NX $18.61
- COLL $29.85
- Analyst Decision
- NX Strong Buy
- COLL Strong Buy
- Analyst Count
- NX 1
- COLL 5
- Target Price
- NX $38.00
- COLL $43.60
- AVG Volume (30 Days)
- NX 592.3K
- COLL 456.4K
- Earning Date
- NX 03-10-2025
- COLL 05-08-2025
- Dividend Yield
- NX 1.72%
- COLL N/A
- EPS Growth
- NX N/A
- COLL 43.56
- EPS
- NX 0.29
- COLL 1.86
- Revenue
- NX $1,438,751,000.00
- COLL $631,449,000.00
- Revenue This Year
- NX $49.00
- COLL $20.00
- Revenue Next Year
- NX $2.89
- COLL $3.93
- P/E Ratio
- NX $64.10
- COLL $16.00
- Revenue Growth
- NX 29.87
- COLL 11.41
- 52 Week Low
- NX $18.14
- COLL $27.28
- 52 Week High
- NX $38.98
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- NX 37.33
- COLL 50.32
- Support Level
- NX $19.53
- COLL $29.33
- Resistance Level
- NX $20.47
- COLL $30.84
- Average True Range (ATR)
- NX 0.69
- COLL 0.84
- MACD
- NX 0.01
- COLL 0.07
- Stochastic Oscillator
- NX 16.73
- COLL 56.29
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.